Cardiac Ischemia Clinical Trial
— CSWTOfficial title:
Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease: A Prospective Randomized Double-blind Control Trial
Verified date | February 2020 |
Source | Beijing Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Coronary heart disease (CHD) is a public health care challenge. There are three types of treatment for CHD, medication, percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG). However, some end-stage CHD patients lost the chance to get those treatment. Cardiac shock wave therapy (CSWT) is a new developed therapy for these patients, which is used in tens of countries all over the world. Safety, invasiveness, effectiveness is its advantage. Ischemia condition can be improved after CSWT. There are only three cities in China run the program of CSWT, which are Kunming, Beijing and Shanghai. The investigators designed a randomized double-blind study to evaluate the effectiveness and safety of CSWT.
Status | Completed |
Enrollment | 30 |
Est. completion date | November 20, 2019 |
Est. primary completion date | November 20, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: 1. Multiple or diffused coronary artery stenosis by coronary angiography and not candidate for PCI or CABG; 2. Myocardial ischemia and/or cardiac dysfunction by objective exams; 3. Angina and/or heart failure could not be control after optimal medication treatment for coronary artery disease; 4. LVEF is above 30%; 5. Signed informed consent Exclusion Criteria: 1. Acute myocardial infarction; 2. Within one month after PCI or CABG; 3. Heart transplant patient; 4. Mechanic valve implantation patient; 5. Uncontrolled heart failure with LVEF less than 30%; 6. Severe arrhythmia; 7. Pacemaker implantation patient; 8. Infective endocarditis; 9. Severe chronic obstructive pulmonary disease patient; 10. Pregnant or nursing patient; 11. Silicone breast forms patient; 12. Chest tumor patient; 13. Participant in other clinical trials at the same time. |
Country | Name | City | State |
---|---|---|---|
China | Beijing Hospital | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Hospital |
China,
Yu W, Shen T, Liu B, Wang S, Li J, Dai D, Cai J, He Q. Cardiac shock wave therapy attenuates H9c2 myoblast apoptosis by activating the AKT signal pathway. Cell Physiol Biochem. 2014;33(5):1293-303. doi: 10.1159/000358697. Epub 2014 Apr 28. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Myocardial perfusion score | Myocardial perfusion score will be calculated by myocardial perfusion imaging though single-photon computer tomography. | 1st week of fourth month from beginning of CSWT | |
Primary | Ischemia area percentage | Ischemia area will be calculated by myocardial perfusion imaging though single-photon computer tomography. | 1st week of fourth month from beginning of CSWT | |
Secondary | Cardiac wall motion amplitude | Cardiac wall motion amplitude rate will be calculated by single-photon computer tomography. | 1st week of fourth month from beginning of CSWT | |
Secondary | Left ventricular thickness rate | Left ventricular thickness rate will be calculated by single-photon computer tomography. | 1st week of fourth month from beginning of CSWT | |
Secondary | Cardiac enzyme | Troponin T and troponin I will be tested at last time shock wave therapy of the first week. | First week after CSWT | |
Secondary | Angina score-SAQ | SAQ angina score will be finished after three month of CSWT. | 1st week of fourth month from beginning of CSWT | |
Secondary | Quality of life (SF-36) | SF-36 questionnaire will be used for QOL. | 1st week of fourth month from beginning of CSWT | |
Secondary | Six-minute of walk test | 6MWT will be used for exertional capacity. | 1st week of fourth month from beginning of CSWT |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06154473 -
Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
|
||
Completed |
NCT03203057 -
Induced Myocardial Ischemia: a Serial Troponin T and Troponin I Measurements
|
N/A | |
Active, not recruiting |
NCT06235424 -
Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement
|
Phase 4 | |
Completed |
NCT03859466 -
Safety and Efficacy of Cardiac Shockwave Therapy in Patients Undergoing Coronary Artery Bypass Grafting
|
N/A | |
Recruiting |
NCT04749212 -
Perioperative Troponin I and NT Pro-BNP in Lung Resection
|
||
Recruiting |
NCT03798652 -
Improved Prediction of Functional Recovery After Revascularisation Using Combined Assessment of Myocardial Ischaemia and Viability by CMR - Pilot Study
|
||
Recruiting |
NCT05726604 -
4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy
|
N/A | |
Completed |
NCT04458155 -
Li-Hep vs. Non-Li-Hep Coated Transfer Device
|
||
Not yet recruiting |
NCT06414330 -
Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery
|
N/A | |
Completed |
NCT02055443 -
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain
|
N/A | |
Completed |
NCT03433963 -
The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution
|
N/A | |
Recruiting |
NCT05757947 -
Study of the No-touch Saphenous Vein Graft
|
N/A | |
Completed |
NCT05164640 -
Ischemia in Patients With Non-obstructive Disease (INOCA) in Italy INOCA IT Multicenter Registry"
|
N/A | |
Completed |
NCT03642730 -
Interactive Guided Ultrasound Examinations Done by Non-experts of Ultrasound Imaging
|
N/A | |
Recruiting |
NCT05006183 -
Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome.
|
N/A | |
Active, not recruiting |
NCT05453097 -
Prognostic Value of the Selvester QRS Score for Perioperative Myocardial Injury Following Non-cardiac Surgery
|
||
Recruiting |
NCT03800082 -
Development and Usability Testing of a Progressive WebApp for Women With Heart Disease
|
N/A | |
Completed |
NCT03857503 -
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)
|